Blood-based RT-PCR assays of MN/CA9 or PSMA: clinical application in renal cancer patients.

[1]  Katz,et al.  Biomarkers of renal cell carcinoma. Past and future considerations. , 2000, Urologic oncology.

[2]  M. Rubin,et al.  The detection of renal carcinoma cells in the peripheral blood with an enhanced reverse transcriptase–polymerase chain reaction assay for MN/CA9 , 1999, Cancer.

[3]  D. Bostwick,et al.  Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma , 1998, Cancer.

[4]  E. Stanbridge,et al.  Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney. , 1997, Cancer research.

[5]  M. Stifelman,et al.  Expression of the tumor-associated gene MN: a potential biomarker for human renal cell carcinoma. , 1997, Cancer research.

[6]  C. Cordon-Cardo,et al.  Prostate-specific membrane antigen expression in normal and malignant human tissues. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[7]  J. Schalken,et al.  Molecular prognostic factor in renal cell carcinoma. , 1996, Seminars in urologic oncology.

[8]  G. Snow,et al.  Squamous cell carcinoma-associated antigens used in novel strategies for the detection and treatment of minimal residual head and neck cancer. , 1996, Anticancer research.

[9]  R. Kettmann,et al.  Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships. , 1996, Genomics.

[10]  E. Levine,et al.  Detection of tyrosinase mRNA from the blood of melanoma patients. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[11]  B. Lacour,et al.  Enhanced detection of hematogenous circulating prostatic cells in patients with prostate adenocarcinoma by using nested reverse transcription polymerase chain reaction assay based on prostate-specific membrane antigen. , 1995, Clinical chemistry.

[12]  J. Isaacs,et al.  Localization and physical mapping of the prostate-specific membrane antigen (PSM) gene to human chromosome 11. , 1995, Genomics.

[13]  K. Pittman,et al.  Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. , 1995, British Journal of Cancer.

[14]  P. Schellhammer,et al.  Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues. , 1995, Urologic oncology.

[15]  R. Kettmann,et al.  Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. , 1994, Oncogene.

[16]  P. Disaia,et al.  Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas. , 1994, The American journal of pathology.

[17]  M. Benson,et al.  Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. , 1994, Urology.

[18]  W. Fair,et al.  Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. , 1993, Cancer research.

[19]  W. L. Davis,et al.  Immunohistochemical and pharmacokinetic characterization of the site-specific immunoconjugate CYT-356 derived from antiprostate monoclonal antibody 7E11-C5. , 1990, Cancer research.

[20]  K. Mullis,et al.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. , 1985, Science.